NICE, the health technology appraisal institute for England and Wales, has issued draft guidance declining to recommend Jevtana (cabazitaxel) from...
Randomised controlled trial (RCT) data suggest that docetaxel (formerly Taxotere from Sanofi and now generic) improves overall survival and time...
Treating women with early stage Breast Cancer using a combination of chemotherapy and the molecularly targeted drug Herceptin (trastuzumab), from...
The National Institute for Health and Care Excellence has in final draft guidance widened the scope of Xofigo (radium Ra...
Generon Corporation announced that the first pivotal phase III study in the U.S. for F 627 to treat chemotherapy-induced neutropenia...
In the fourth part of our four-part series detailing targeted breast cancer therapies, we focus on the most aggressive and difficult to treat triple negative breast cancer subtype.